Question: is alirocumab approved by fda?
Answer: (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration ( FDA ) has approved Praluent® (alirocumab) to reduce the risk of heart attack, stroke and unstable angina requiring hospitalization in adults with established cardiovascular (CV) disease.